Abstract During the process of differentiation, osteoblasts commit through strictly controlled checkpoints under the influence of several growth factors, cytokines, and extracellular matrix (ECM) proteins. The mineralized tissue-specific ECM component osteoadherin (OSAD) belongs to the small leucine-rich repeat protein family of proteoglycans. Proteoglycans modulate cellular behavior either through the attached glycosaminoglycan chains or by direct protein-protein interactions via the core protein sequences. Leucine-rich repeats have been shown to directly interact with cell-surface receptors such as epidermal growth factor receptor, blocking its ability to bind its ligand. In the present study, we investigated the influence of OSAD on the behavior and maturation of MC3T3E1 osteoblasts. OSAD overexpression and repression clones were created by stably transfecting with plasmids coding for either mouse OSAD cDNA or small-hairpin RNA, targeted against mouse OSAD. Overexpression of OSAD resulted in an increase of osteoblast differentiation features, such as increased alkaline phosphatase (ALP) activity and increased in vitro mineralization, as well as reduced proliferation and migration. Bone sialoprotein (BSP) levels were unchanged, while upregulation of osteocalcin (OC) and osteoglycin (OGN) was observed. Conversely, repression of OSAD expression resulted in increased cell proliferation and migration. BSP and OC were unaffected, while OGN was downregulated. ALP activity was reduced, though no change in in vitro mineralization was observed. We conclude that OSAD overexpression enhanced the differentiation and maturation of osteoblasts in vitro.
Osteogenesis is the process whereby mesenchymal stem cells differentiate through a series of events resulting in bone-producing osteoblasts and ultimately the bone tissue maintaining osteocytes [for review, see 1]. In vivo, mature osteoblasts cease proliferation and begin secretion of the components that will later constitute the extracellular matrix (ECM) of bone [reviewed in 2]. The changes in cellular behavior are accomplished by signaling events from several factors, together with the functional regulation of surface receptors [for review, see 1, 3] . Important factors in bone development are the transforming growth factor-b (TGF-b) superfamily cytokines TGF-b1, -b2, and -b3 and bone morphogenetic proteins (BMPs) -2, -4, and -7 [reviewed in 4] . Other factors include fibroblast growth factor-2 [5, 6] , epidermal growth factor (EGF) [7, 8] , and many others [9] .
In the development and maintenance of bone tissue, osteoblasts secrete a variety of proteins and factors into the surrounding matrix [10] [11] [12] [13] [14] [15] . Bone contains a multitude of different proteins typical for ECM, and a group of very important proteins in tissues with high order matrix are the proteoglycans [16, 17] . Functions of different proteoglycans vary, but commonly they enhance the signaling of circulating factors and in some instances affect cell behavior directly [18, 19] . However, as a specialized tissue, bone also contains proteoglycans specific to mineralized matrices. One such proteoglycan is osteoadherin (OSAD), which is a member of the small leucine-rich proteoglycan (SLRP) family [13, 20, 21] . OSAD is secreted into the matrix at the time of mineralization and is proposed to be a reliable marker for mature odontoblasts and osteoblasts [22] [23] [24] [25] [26] . The leucine-rich repeat (LRR) motif of OSAD is a dominant feature, comprising most of the core protein, while the acidic C terminus probably allows for binding to the hydroxyapatite of bone matrix [13] . As such, OSAD has a suggested function in the bridging of cells to the ECM of bone, although others have proposed that OSAD, similar to other proteoglycans, could act as a signaling molecule [25] , as is the case for another well-studied SLRP, decorin (DCN). DCN has been shown to directly interact with cell-surface receptors, such as insulin-like growth factor-I receptor [27] , TGF-b receptor [28, 29] , and EGF receptor (EGFR) [30] ; and this interaction has been shown to be specifically mediated by the LRR sequence [31] . EGFR is a high-affinity receptor for EGF [32] , and its upregulation has been noted in lung cancer bone metastasis [33] and linked to a poor prognosis in breast cancer; also, it may promote proliferation, migration, invasion, and cell survival, as well as inhibition of apoptosis [34, 35] .
In our study, we sought to determine how the proteoglycan OSAD affected the behavior of osteoblasts. Our approach was to stably overexpress OSAD or to stably knockdown OSAD by the expression of small-hairpin RNA (shRNA), specifically targeted against OSAD mRNA in the mouse calvariae osteoblast cell line MC3T3E1. In addition, we treated cells in culture with recombinantly expressed mouse OSAD protein. From our results we concluded that the maturation state of osteoblasts was increased by OSAD, as evidenced by a decrease in proliferation and increases in mineralization and late osteoblast maturation markers.
Materials and Methods

Cell Culture of MC3T3E1 Cells
The immortalized mouse calvariae osteoblast cell line MC3T3E1 clone 4 (American Type Culture Collection, Rockville, MD) was maintained in alpha-modified minimum essential medium (aMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS) (all cell culture reagents from Invitrogen, Carlsbad, CA). Culture conditions at 37°C, 5% CO 2 , and a humidified atmosphere were in accordance with the supplier's protocol.
Generation of OSAD Overexpression Vector
Oligonucleotides (all purchased from Cybergene, Huddinge, Sweden) 5 0 -AAT TAC TAG TCT TAA GAC CGG   TGA ATT CGGT AA CCG CTA GCT GTA CAG CGG  CCG CTG TG-3  0 and 5  0 -GCG GCC GCT GTA CAG CTA  GCG GTT ACC GAAT TCA CCG GTC TTA AGA CTA  GT- (OSAD repression), the nontarget control sequence 5 0 -GGA ATC TCA TTC GAT GCA TAC-3 0 (transfection control), or the pUIN-OSAD vector (OSAD overexpression) using FuGENE6 (Roche) in accordance with the supplier's recommendations. The cells were selected with 200 lg/mL of G418 (Invitrogen) in aMEM supplemented with 10% FCS for 4 weeks and then maintained with 100 lg/mL of G418. Gene overexpression or repression was confirmed by real-time quantitative PCR (qPCR) analysis with gene expression assay primers for OSAD (Mm00449589_m1; Applied Biosystems, Foster City, CA).
Osteogenic Differentiation
Untransfected, transfection control, OSAD-repressed, and OSAD-overexpression MC3T3E1 cells were seeded into the wells of six-well plates and allowed to grow to confluence in aMEM, 10% FCS, after which the medium was changed to osteogenic conditions (aMEM, 10% FCS, 10 mM b-glycerophosphate, 50 lg/mL L-ascorbic acid-2-phosphate). Osteogenic supplemented cells were allowed to grow for up to 21 days, as indicated in the separate experiments.
PCR Analysis of Gene Expression
RNA from MC3T3E1 cells cultured in osteogenic differentiation media for 3, 6, and 9 days was collected using TRIzol (Invitrogen). One microgram was reverse-transcribed using the SuperScript III Reverse Transcription Kit (Invitrogen) and oligo dT primers in accordance with the provided protocol. OSAD primers 5 0 -ATG GTG TAT TCG CTA AAC TTT CAA-3 0 and 5 0 -AAG ATG ATT ATA GCA GAG GTC AAG-3 0 , bone sialoprotein (BSP) primers 5 0 -ACC GGC CAC GCT ACT TTC TTT AT-3 0 and 5 0 -TCC TCG TCG CTT TCC TTC ACT TT-3 0 , and GAPDH primers 5 0 -TGT GAA CGG ATT TGG CCG TA-3 0 and 5 0 -GGA AGG CCA TGC CAG TGA GC-3 0 were used. PCR conditions were 95°C, 2 minutes, followed by 30 cycles at 95°C for 30 seconds, 50°C for 30 seconds, and 72°C for 1 minute; and the reaction was finished at 72°C for 10 minutes. PCR products were analyzed on a 2% agarose gel stained with ethidium bromide.
Real-Time qPCR
Confluent cells were detached by trypsin treatment and spun down at 300 9 g for 10 minutes, and total RNA was isolated in accordance with RNeasy Mini Spin Kit (Qiagen, Chatsworth, CA). Total RNA (5 lg) was reverse-transcribed using the High Capacity cDNA Archive Kit (Applied Biosystems), and real-time qPCR was performed with gene expression assay primers for OSAD (Mm00449589_m1), BSP (Mm00492555_m1), osteoglycin (OGN, Mm01349370_m1), osteocalcin (OC, 459080 A12), and 18S (4319413E) in the 7500 system using the supplier's protocol (Applied Biosystems). Relative gene expression was calculated using the DDCt method, where 18S was the endogenous control and untransfected or transfection control samples were calibrators.
Alkaline Phosphatase Assay
Untransfected, transfection control, OSAD-repressed, and OSAD-overexpression MC3T3E1 cells differentiated for 7 days were washed in Dulbecco's phosphate-buffered saline (D-PBS, Invitrogen) three times and then collected by scraping in D-PBS and 0.05% Triton. Cell lysates were sonicated and spun down briefly, and the supernatant was used for measuring the activity of the enzyme by incubation with the substrate para-nitrophenylphosphate in diethanolamine buffer (1 mg/mL), pH 9.8. Alkaline phosphatase (ALP) activity was determined by reading the absorbance at 405 nm, comparing with a para-nitrophenol standard curve measurement, and normalizing against the protein concentration of the sample. Protein concentration was determined using the Protein Assay Kit (Bio-Rad, Richmond, CA) and measuring at 650 nm.
Scratch-Wound Assay
Transfected and control MC3T3E1 cells were seeded in triplicates into the wells of 24-well plates in aMEM, 10% FBS with or without osteogenic supplementation. The cells were allowed to grow until confluent, and then a wound was created in the cell layer by scratching with a sterile pipette tip. Cells were photographed immediately after scratching and then left to grow for a further 48 hours, at which time they were fixed in 4% formaldehyde for 15 minutes at room temperature and stained with GiemsaWright stain. Photographs were taken of the wounded area, and the distances between cell layer edges were measured.
Protein Isolation and Western Blotting
Total protein was collected from cells in culture by lysis in Tris-buffered saline (TBS) at pH 7.4 with 1% Triton and protease inhibitors. Cell nuclei and debris were separated from the protein lysate by brief centrifugation. Protein was precipitated in ethanol/50 mM sodium acetate at -20°C overnight and collected by centrifugation at 10,000 9 g for 30 minutes at 4°C. The protein pellet was dissolved in 1% sodium dodecyl sulfate (SDS) and Laemmli buffer (BioRad).
Total protein extracts were separated on a 4-15% gradient SDS polyacrylamide gel (Bio-Rad) in 25 mM Tris, 0.1 M glycine, and 0.05% SDS running buffer and subsequently transferred to a nitrocellulose membrane (GE Healthcare, Waukesha, WI) by semidry transfer using stacked filter paper (3M, Bracknell, UK) soaked in 48 mM Tris, 39 mM glycine, and 20% methanol buffer at 1 mA/ cm 2 constant current. Blocking of membranes was performed at room temperature by incubation in blocking solution (TBS, 0.2% Tween-20, [TBS-T], 5% nonfat dry milk [Semper, Sundbyberg, Sweden]). Primary antibodies goat a-OSAD (R&D Systems, Minneapolis, MN) at 1:10,000 dilution, rabbit a-EGFR (Santa Cruz Biotechnologies, Santa Cruz, CA) at 1:100 dilution, and rabbit a-actin (Sigma, St. Louis, MO) at 1:10,000 dilution in blocking solution were incubated with membranes at 4°C overnight. Secondary antibody rabbit-a-goat or goat-a-rabbit conjugated to horseradish peroxidase (HRP; Dako, Glostrup, Denmark) diluted 1:10,000 in blocking solution was incubated with membranes for 1 hour at room temperature. Membranes were washed extensively in TBS-T between and after antibody incubations. HRP was activated using the ECL Plus Kit (GE Healthcare), exposed to photographic membranes (GE Healthcare), and developed using a Curix 60 machine (Agfa-Gevaert, Mortsel, Belgium).
Recombinant Expression of Mouse OSAD
Mouse OSAD cDNA was cloned into the pQE30 expression vector (Qiagen) and chemically transformed into Escherichia coli. Recombinant expression was performed in exponentially dividing cells by isopropyl-b-D-1-thiogalactopyranoside induction. Cells were collected by centrifugation and lysed (6 M GuHCl, 0.1 M NaH 2 PO 4 , 10 mM imidazole [Sigma], 10 mM Tris [pH 8], 0.5 M NaCl, 0.2% Nonidet-P40, 5 mM N-ethylmaleimide) by stirring for 1 hour at room temperature, followed by homogenization through a 20G needle. Debris was collected by centrifugation at 14,000 9 g for 25 minutes, and the supernatant was filtered through 0.22-lm filter. Recombinant OSAD was loaded onto a HiTrap column (GE Healthcare) and purified by affinity chromatography. After application of the sample, the column was washed with 5 9 vol. . Fractions confirmed to contain the protein were subjected to another round of purification on a hydroxyapatite (Bio-Rad) column equilibrated with 20 mM Tris (pH 7.6). Fractions were exchanged into a Tris-phosphate buffer (20 mM NaPO 4 , 20 mM Tris [pH 7.6]) prior to application to column, and the protein was eluted over an NaPO 4 gradient ranging 20-200 mM. The collected fractions were dialyzed into PBS, and the protein concentration was determined using the BCA Protein Assay Kit (Pierce, Rockford, IL). Protein was analyzed by SDS-polyacrylamide gel electrophoresis stained with Coomassie, and the identity of the excised gel fragment was determined by matrix-assisted laser desorption ionization (MALDI) mass spectrometry (Protein Analysis Center, Karolinska Institutet, Stockholm, Sweden).
Cell Proliferation Assay
OSAD-repression and -overexpression cells as well as control transfected and untransfected cells were detached by trypsin treatment and counted in a Neubauer hemocytometer. Cells were diluted to 1 9 10 4 /mL and seeded into 96-well plates with 100 lL/well. The Cell Proliferation Kit (Roche) was used in accordance with the manufacturer's protocol to determine the proliferation rate over a 14-day period. In addition, proliferating cells were treated with recombinant OSAD at 0.1, 1, or 10 nM concentrations and compared with cells proliferating in regular culture medium or osteogenic supplementation medium. Cell cultures were left to expand, and MTT measurements were performed at 0-3 days.
Apoptosis Assay DNA from untransfected, transfection control, OSADrepressed, and OSAD-overexpression MC3T3E1 cells cultured with or without osteogenic supplementation was collected and analyzed by the Apoptotic DNA Ladder Kit (Roche) in accordance with the provided protocol.
Alizarin Red S Staining OSAD-overexpression and OSAD-repression cells together with their controls (untransfected and transfection control, respectively) were subjected to osteogenic differentiation. After the culture period (0, 14, and 21 days), the cells were rinsed in D-PBS and fixed in ice-cold 70% ethanol for at least 1 hour. Another round of rinsing in D-PBS was followed by staining with 40 mM alizarin red S (SigmaAldrich, St. Louis, MO) solution (pH 4.2) for at least 10 minutes. Alizarin red S background stain was removed by extensive washing with TBS, and the stained cell cultures were dehydrated through a graded series of 70%, 95%, and 99.5% ethanol for 10 minutes each. As an alternative to dehydration, the alizarin red S staining was extracted by acetic acid as described by Gregory et al. [36] and quantified by absorbance spectrophotometry at 405 nm.
All experiments were repeated independently at least twice, and data are averages of independent statistically significant results. Statistical analysis was performed using the paired t-test method with Excel software (Microsoft, Redmond, WA) or analysis of variance with Statistica 8 (StatSoft, Tulsa, OK) when multiple groups were compared.
Results
OSAD Gene Expression in Differentiating MC3T3E1 Osteoblasts
OSAD expression was assayed in differentiated and nondifferentiated MC3T3E1 cells and compared with the expression of BSP (Fig. 1) . At day 3, OSAD was undetectable in undifferentiated cells, and only low-intensity
signals were found at days 6 and 9. However, in the differentiated cells, OSAD was found from day 3 and further increased over the culture period. In contrast, BSP was found at all time points and increased with differentiation.
Osteogenic Differentiation Marker Gene Expression in MC3T3E1 Cells with Altered OSAD Expression
In order to assay for the effects of OSAD expression on osteoblasts, we created stable osteoblastic cell lines either overexpressing the OSAD cDNA or expressing shRNA, specifically directed against OSAD. OSAD expression in the clones was determined by Western blotting (Fig. 2) . The expression levels in the overexpressing cells were found to be constitutively increased, while only a slight inhibition was found in OSAD-repressing cells cultured in nonosteogenic conditions and repression was stronger in cells cultured in osteogenic conditions. Transcript levels were also assayed by real-time qPCR and found to be significantly increased by OSAD overexpression (on average 5.3-fold vs. untransfected, 95% confidence interval [CI] ± 0.41, n = 8, P \ 0.001) with pUIN-OSAD overexpression clone (Fig. 3A) . OSAD repression resulted in a strong inhibition (on average 0.07-fold vs. transfection control, 95% CI ± 0.010, n = 5, P = 0.03) with SureSilencer anti-OSAD shRNA (Fig. 3B) . Further analysis of osteoblast markers BSP and OC revealed that BSP was only slightly affected by OSAD overexpression to 1.55-fold induction (95% CI ± 0.31, n = 6) or OSAD repression to 0.83 (95% CI ± 0.12, n = 6) ( Fig. 3A and B, respectively), while OC was strongly upregulated with OSAD overexpression to 4.37-fold (95% CI ± 1.60, n = 6, P = 0.002) (Fig. 3A) but unaffected by OSAD repression, remaining at 1.04-fold (95% CI ± 0.25, n = 6, Fig. 3B ). OGN was found to be expressed in close association with OSAD expression levels, where OSAD overexpression resulted in a 4.1-fold induction (95% CI ± 1.92, n = 6, P \ 0.001) of OGN, while OSAD repression resulted in 0.32-fold levels of OGN (95% CI ± 0.11, n = 6, P = 0.005) (Fig. 3A and B, respectively).
ALP Activity
To further investigate how OSAD expression affected osteoblast differentiation, the cells were differentiated into mature osteoblasts by supplementing the culture media with ascorbic acid and b-glycerophosphate. After 1 week in osteogenic conditions, the cells were assayed for their ALP activity. Overexpression of OSAD led to a 1.69-fold increase in ALP activity (95% CI ± 0.040, P = 0.009), while repression of OSAD led a decrease to 0.63-fold (95% CI ± 0.037, P = 0.02) in ALP activity (Fig. 4) .
Proliferation of OSAD-Overexpressing and OSAD-Repressing MC3T3E1 Osteoblasts
The effect of OSAD on proliferation was assayed by performing an MTT assay on the MC3T3E1 cell clones either overexpressing or repressing OSAD (Fig. 5A ). Virtually no proliferative activity was detected with OSAD-overexpressing cells until the fifth day of culture. However, the cells started to proliferate after this time point, but the cell population never attained the same levels as the untransfected cells or the OSAD-repressed cell populations. The OSAD-repressed cells showed no distinguishable difference relative to wild-type control cells initially, but after the seventh day of culture they started to differ by increasing their proliferation rate. Proliferation continued at a higher rate until the end of the culture period. No increase in apoptotic cells was apparent, nor was any increase of dying cells in the cultures. Nonetheless, we examined whether the decreased number of proliferating osteoblasts overexpressing OSAD could be due to an increase in apoptosis. We analyzed OSAD-overexpression cells, OSAD-repression cells, and control cells for increased DNA fragmentation. No change in DNA fragmentation was found with any of the cells tested (data not shown).
As a possible explanation for the changes in cellular proliferation, we examined how EGFR, which is an important signaling molecule in osteoblast migration and proliferation [37] , was affected by the changes in OSAD Supplementation of mouse OSAD resulted in inhibition of proliferation at 10 nM concentration, but no effect was observed at 1 nM or lower. Results are displayed as formazan absorption ±95% CI, n = 6 for all samples. *P \ 0.05, ***P \ 0.001 expression. We found that OSAD-overexpressing cells exhibited a shift of signal intensity toward the unphosphorylated receptor with a size of 140 kDa, which corresponds to the unactivated receptor, whereas OSADrepressed cells and control cells exhibited a strong signal for the size of the phosphorylated receptor of 170 kDa, which corresponds to the activated receptor (data not shown).
MC3T3E1 Proliferation Is Affected by OSAD Supplementation
We added purified, recombinantly expressed mouse OSAD to proliferating MC3T3E1 cells at 0.1, 1, and 10 nM concentration (Fig. 5B) . After the first day, an apparent difference in cell number was observed at 10 nM, which never recovered over the testing period. Furthermore, no proliferation was observed with 10 nM OSAD-treated cells at all compared with cells in normal culture medium or cells in culture medium with osteogenic supplementation, which expanded readily. Supplementation with 0.1 or 1 nM OSAD did not affect proliferation, and the cells behaved in a similar manner to controls. Due to limitations in available recombinant OSAD, our experiments were restricted to the above-mentioned time points.
Scratch-Wound Assay
To further explore the cellular effects of altered OSAD expression, we performed the scratch-wound assay. Scratching of the cell layer triggers a migratory event similar to the events in fracture healing and after resorption. We found that OSAD-overexpressing cells had a greatly impaired ability to close the wounded area (Fig. 6A) , while OSAD-repressed cells had an increased ability to close the scratched wound (Fig. 6B) . After 48 hours, gap closure in OSAD-overexpression cells was reduced to 64% (95% CI ± 4.6%, n = 3, P = 0.03) and 68% (95% CI ± 4.6%, n = 3, P = 0.03) in regular and osteogenic conditions, respectively. OSAD repression resulted in an increase in gap closure by 140% (95% CI nondeterminable, n = 3, P = 0.02) and 158% (95% CI ±11%, n = 3, P = 0.01) in regular and osteogenic culture conditions, respectively (Fig. 6C ).
Osteogenic Differentiation
The alizarin red S staining assay indicates the presence of deposited calcium in culture and of in vitro mineralization, and staining can be measured spectrophotometrically after Distances between migration fronts were measured and compared as OSAD overexpression vs. untransfected and OSAD repression vs. transfection control. Y error bars are ±95% CI, n = 3 for all samples dye extraction. We subjected OSAD-overexpressing, OSAD-repressing, and control cells to in vitro differentiation by culturing in medium with or without osteogenic supplementation for 21 days. Control cultures did not mineralize and subsequently did not stain with alizarin red S (not shown). Differences in mineralization and nodule formation were apparent after 14 days of culture with OSAD-overexpressing cells (Fig. 7) and could also be detected by absorbance spectrophotometry of the extracted dye (1.30-fold increase, standard deviation [SD] ± 0.097, n = 2, P = 0.048) but not with OSAD-repressing clones (1.24, SD ± 0.16, n = 2, P = 0.15). After 21 days of osteogenic differentiation, the difference in mineralization with OSAD-overexpressing cells was further attenuated (1.33, SD ± 0.080, n = 3, P = 0.039), while OSADrepressing cells did not differ from control cells (1.42, SD ± 0.11, n = 3, P = 0.20).
Discussion
In this study, we examined the functional role of the SLRP OSAD on osteoblasts. By means of stable transfections of the mouse preosteoblast cell line MC3T3E1, we either introduced an shRNA-expressing plasmid with a sequence specifically targeted against OSAD or an overexpression plasmid containing mouse OSAD cDNA under the influence of the human ubiquitin C promoter. We chose the ubiquitin C promoter over the CMV promoter since it has been shown to be downregulated in differentiating osteoblasts [38] . Our results suggest not only that OSAD was specifically upregulated by terminally differentiated osteoblasts but also that OSAD promotes the differentiation of osteoblasts into mature cells in culture.
OSAD is a proteoglycan only located to mineralized tissues [13, 21, 22, 25, 39] . Osteoblasts and odontoblasts of bone and dentine are the most probable targets of OSAD action since they come in contact with the protein when the matrix is being laid down and when the tissue is being rebuilt after resorption or injury. Upon resorption by osteoclasts, factors entrapped in the matrix are released and can signal the initiation of bone matrix synthesis to osteoblasts. Such events in bone matrix homeostasis have been termed ''coupling'' [reviewed in 40] , and osteoclast activity has been linked to an increase in OSAD expression by osteoblasts [41] .
The expression and function of bone ECM proteins have been reviewed extensively [1, 42] . BSP and OC are considered the most reliable bone-specific matrix proteins, where BSP is expressed at the preosteoblast stage and during differentiation, while OC is expressed in osteoblasts at the stage of matrix production and mineralization. Furthermore, many matrix proteins are not just restricted to bone but found in mineralized matrices, including fibronectin [43] , osteopontin [44] , and OGN [45, 46] , also known as ''osteoinductive factor'' [47, 48] . Interestingly, OGN is also a member of the SLRP family of proteins, but the most abundant and well studied are DCN and biglycan (BGN). In the knockout model BGN has a more severe bone phenotype than DCN, with osteopenia as a result, while in the DCN/BGN double knockout model this phenotype was strongly increased [49] . This result highlights the compensation and/or redundancy between various ECM proteins in their biological functions. SLRPs are found throughout tissues with a highly ordered ECM [reviewed in 16] . Their influence on cellular behavior and association to cell-surface receptors has been thoroughly investigated. For instance, DCN inhibits the proliferation of Chinese hamster ovary cells [50] and carcinoma cells [19] , in an inhibition which is probably mediated by sequestering growth factors [reviewed in 51] or by direct inhibition of receptor function [30] .
In the current study, we analyzed how OSAD was expressed by differentiating MC3T3E1 osteoblasts and compared it with the expression pattern of BSP. The expression patterns of OSAD and BSP in vivo have been reported to be similar [25] . While BSP was found at high levels in preosteoblasts, OSAD expression was upregulated when cultured with osteogenic supplements, thereby suggesting to us that OSAD was specifically induced with osteoblast terminal differentiation. The influence of OSAD on the expression pattern of osteoblast differentiation markers was explored in MC3T3E1 cells with altered OSAD expression. There was a strong increase with OC and OGN in OSAD-overexpressing cells, while BSP was virtually unaffected. On the other hand, only OGN was inhibited by OSAD-repressing cells, while BSP and OC were unaffected. A previous study demonstrated that BSP upregulates the differentiation phenotype markers of osteoblasts [52] . Since OSAD was upregulated later than BSP in osteoblast differentiation, it was not surprising that BSP was unaffected by the alteration of OSAD expression, while OC and OGN were upregulated, especially since OC has been associated with a mature osteoblast phenotype [53] and OGN was initially isolated from bovine bone as an inducer of matrix mineralization [48] . BSP and OSAD are similar in their ability to bind a v b 3 integrin and hydroxyapatite [13, 44, 54] and are spatially colocalized [25] . Therefore, it is not unlikely that OSAD could also exert similar functions in determining cell fate. OSAD repression did not show any effect on BSP and OC, while the effect on OGN was strong. This implies that OSAD may not be required for the regulation of osteoblast differentiation markers. OGN and OSAD, in both mouse and human, are genomically juxtaposed and their expression is tightly coregulated in the gene cluster comprising OGN, OSAD, and Asporin, all involving both upstream and downstream elements [55] . It is possible that OGN is affected by an auto-feedback inhibition similar to that which has been demonstrated to occur for BSP [56] .
ALP activity was enhanced in OSAD-overexpressing cells and decreased in OSAD-repressed cells, which further strengthens our hypothesis that OSAD influences the terminal differentiation of osteoblasts. ALP activity in bone reflects the state of activity in the matrix-producing osteoblasts [reviewed in 57], and a similar effect on ALP has been demonstrated with studies on cells subjected to altered levels of BSP in culture [58] .
Differentiating osteoblasts decrease in proliferation [reviewed in 1]. We found that OSAD overexpression resulted in inhibited cell proliferation while OSAD repression increased cell proliferation, which is in line with our finding that OSAD increased the expression of late differentiation markers. The effects of OSAD repression became apparent after the seventh day of proliferation as the cells continued to proliferate at a higher rate than the control cells. This time in culture reflects when OSAD was being upregulated in MC3T3E1 cells and in the control setting would inhibit the continued proliferation of the cells.
A significant proportion of OSAD core protein comprises the LRR, which allows SLRPs to bind other proteins, such as growth factors or cell-surface receptors [reviewed in 59], as do the glycosaminoglycans attached to the core protein [reviewed in 17] . Of the many receptors involved in osteoblast maturation and mineralization, EGFR is an example of how LRR proteins inhibit receptor function by direct interactions [18] . EGFR is upregulated in bone metastasizing cancers, and blocking the receptor results in a reduction of tumor size [60, 61] . In our experiments, we observed a decrease in the amount of activated receptor with OSAD-overexpressing cells. Decreased EGFR signaling results in reduced osteoblast migration and proliferation with concomitant impairment of proper endochondral ossification, as demonstrated with EGFRdeficient mice [37] . Studies with DCN have previously shown that binding to EGFR causes inhibition of function by internalization of the receptor [62, 63] , which could be a possible mechanism also within our model system with the overall effect of receptor signaling inhibition. Supplementation with recombinant OSAD led to an arrest in proliferation, probably facilitated through the core protein sequence since our recombinant protein was bacterially expressed and did not result in the addition of any glycosaminoglycans.
From our data, SLRP OSAD appeared to affect the behavior of cells in its close vicinity, a feature previously demonstrated in the SLRP family, e.g., BGN, DCN, and fibromodulin [11, 64, 65] . The impaired migration of OSAD-overexpressing cells indicated a more mature phenotype since the migration of preosteoblasts is thought to be essential for organized bone formation, remodeling, and repair after fracture [reviewed in 66] . Impaired migration has been described with overexpression of DCN in endothelial cells [67] , while BGN enhances the migration of smooth muscle cells [68] . Apparently, there is no consistent effect of SLRPs on cellular behavior, and the increased migration of OSAD-repressed cells could thus be more complex. SLRPs generally bind collagen [reviewed in 10] , and OSAD has been described as a cell attachment molecule with an affinity for integrin a v b 3 , thus anchoring the cells to the surrounding ECM substrate [13] . A looser attachment of the cells could explain the increase in migration by OSAD-repressed cells.
OSAD is a secreted ECM protein of bone and has been implicated in functions related to mineralization, mostly due to its acidic carboxy terminus [21] , which may facilitate an affinity for hydroxyapatite. We found that in vitro mineralization was enhanced by OSAD-overexpression cultures but unaffected by OSAD repression. No bone phenotype has been described for an OSAD knockout mouse (Deltagen and Lexicon knockout mice and phenotypic data, www.informatics.jax.org), but studies with other SLRPs have shown that there is redundancy between ECM molecules [49] . We cannot conclude that OSAD has a direct effect on mineralization since in cultures without osteogenic supplementation no staining was apparent with OSAD overexpression, as with the control cultures.
However, the increased mineralization in osteoinduced overexpression cultures suggests that OSAD may enhance the signaling of maturation in cultured osteoblasts.
Based on our results in this study, we believe that OSAD specifically inhibits proliferation and migration and generally enhances in vitro differentiation, which results in an increase of downstream osteogenic gene products.
